文献速递产科母胎医学

妊娠期高血压疾病患者家庭血压监测与临床血压测量的一致性评估

Is home blood-pressure monitoring in hypertensive disorders of pregnancy consistent with clinic recordings?
PubMed 文献 · Ultrasound Obstet Gynecol · 2018-09-10

本研究为2016至2017年在伦敦圣乔治医院开展的队列研究,纳入147例妊娠期高血压疾病孕妇,比较家庭血压监测(HBPM)与临床血压测量的一致性。结果显示家庭收缩压和舒张压均显著低于临床测量,临床诊断的显著高血压发生率是HBPM的4至5倍。作者认为HBPM可能减少假阳性诊断和不必要的干预,但需权衡漏诊真阳性的风险,亟需前瞻性研究确定HBPM相关血压阈值及监测间隔和频率。

要点

  • 家庭收缩压中位数132.0 mmHg显著低于临床138.0 mmHg(P<0.001)。
  • 家庭舒张压中位数85.0 mmHg显著低于临床89.0 mmHg(P<0.001)。
  • 临床诊断的显著收缩压和舒张压高血压发生率是HBPM的4至5倍。

核心结论

  • 在妊娠期高血压疾病孕妇中,家庭血压低于临床血压,与非妊娠成人观察一致;HBPM可能减少严重高血压假阳性诊断和不必要医疗干预,但须权衡漏诊真阳性的风险;亟需前瞻性研究确定HBPM相关血压阈值及监测间隔和频率。

研究设计与样本

  • 2016至2017年在伦敦大学圣乔治医院开展的队列研究,纳入147例妊娠期高血压疾病孕妇,纳入标准为慢性高血压、妊娠期高血压或子痫前期高风险、无明显蛋白尿且无血液学或生化异常。
  • 每例患者按英国国家卫生与临床优化研究所指南根据个体风险制定个性化医院访视和血压测量计划,取最接近该次医院访视的临床血压测量与HBPM读数配对分析,每例患者仅使用一对测量值。

主要发现

  • 共分析147例女性的294次血压测量;家庭收缩压中位数132.0 mmHg(IQR 123.0-140.0)显著低于临床138.0 mmHg(IQR 132.0-146.5),P<0.001。
  • 按孕周分层,除23-32周(P=0.057)外,各孕周家庭收缩压均显著低于临床。
  • 家庭舒张压中位数85.0 mmHg(IQR 77.0-90.0)显著低于临床89.0 mmHg(IQR 82.0-94.0),P<0.001;按孕周分层,5-14周(P<0.001)、15-22周(P=0.008)和33-42周(P<0.001)家庭舒张压均显著低于临床。
  • 基于临床血压的显著收缩压和舒张压高血压发生率分别是基于HBPM的4至5倍(P<0.001和P=0.005)。

临床怎么用

  • 原文未据此给出推荐;作者认为HBPM有潜力减少妊娠期高血压疾病女性严重高血压假阳性诊断和不必要医疗干预,但须仔细权衡漏诊真阳性诊断的风险。

局限性

  • 原文报告亟需前瞻性研究探讨HBPM在孕妇中的应用,以确定HBPM相关血压阈值及监测间隔和频率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the agreement between home blood-pressure monitoring (HBPM) and blood-pressure measurements in a clinic setting, in a cohort of pregnant women with hypertensive disorders of pregnancy (HDP). METHODS: This was a cohort study of 147 pregnant women with HDP conducted at St George's Hospital, University of London, London, UK, between 2016 and 2017. Inclusion criteria were chronic hypertension, gestational hypertension or high risk of developing pre-eclampsia, no significant proteinuria and no hematological or biochemical abnormalities. Each included patient was prescribed a personalized schedule of hospital visits and blood-pressure measurements, according to their individual risk as per UK National Institute for Health and Care Excellence guidelines. The blood-pressure measurement at the clinic and the HBPM reading obtained closest to that hospital visit were paired for analysis. Only one pair of measurements was used per patient. Differences between home and clinic blood-pressure measurements were tested using the Wilcoxon signed rank test or paired t-test, and were also assessed visually using Bland-Altman plots. Comparison of the binary outcomes was performed using McNemar's chi-square test. Subgroup analysis was performed in the following gestational-age windows: < 14 weeks, 15-22 weeks, 23-32 weeks and 33-42 weeks' gestation. RESULTS: A total of 294 blood-pressure measurements from 147 women were included in the analysis. Median systolic HBPM measurements were significantly lower than clinic measurements (132.0 (interquartile range (IQR), 123.0-140.0) mmHg vs 138.0 (IQR, 132.0-146.5) mmHg; P < 0.001). When stratified according to gestational age, systolic blood-pressure measurements obtained at home were significantly lower than those at clinic in all gestational-age periods except 23-32 weeks' gestation (P = 0.057). Median diastolic blood-pressure measurements at home were also significantly lower than those at clinic (85.0 (IQR, 77.0-90.0) mmHg vs 89.0 (IQR, 82.0-94.0) mmHg; P < 0.001). When stratified according to gestational age, diastolic HBPM measurements were significantly lower in the periods 5-14 weeks (P < 0.001), 15-22 weeks (P = 0.008) and 33-42 weeks (P < 0.001), compared with clinic measurements. The incidence of clinically significant systolic and diastolic hypertension based on clinic blood-pressure measurements was four to five times higher than that based on HBPM measurements (P < 0.001 and P = 0.005, respectively). CONCLUSIONS: Our study shows that, in women with HDP, blood pressure measured at home is lower than that measured in a clinic setting. This is consistent with observations in non-pregnant adults, in whom home and ambulatory monitoring of hypertensive patients is recommended. As such, HBPM has the potential to reduce the number of false-positive diagnoses of severe hypertension and unnecessary medical interventions in women with HDP. This must be carefully weighed against the risk of missing true-positive diagnoses. Prospective studies investigating the use of HBPM in pregnant women are urgently needed to determine the relevant blood-pressure thresholds for HBPM, and interval and frequency of monitoring. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Kalafat E, Mir I, Perry H, et al. Is home blood-pressure monitoring in hypertensive disorders of pregnancy consistent with clinic recordings? Ultrasound Obstet Gynecol. 2018. PMID: 29786155. doi:10.1002/uog.19094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。